• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Highmark Covers AppliedVR’s RelieVRx for Chronic Back Pain

by Fred Pennic 09/09/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Highmark, a commercial health insurance plan, has announced coverage for RelieVRx, a virtual reality-based therapy for chronic low back pain. 

– This landmark decision makes RelieVRx accessible to over four million Highmark members.

A Breakthrough Treatment for Chronic Back Pain

RelieVRx is a fully immersive VR experience designed to empower individuals with skills for managing chronic low back pain (CLBP). Clinically proven to reduce pain intensity and interference, RelieVRx offers a cost-effective, non-pharmacologic treatment option.

How RelieVRx Works

Chronic pain imposes a significant economic burden on the United States, estimated at $635 billion annually. RelieVRx offers a potential solution for managing chronic back pain and reducing its associated costs.

RelieVRx features a 56-session program that addresses the bio-psycho-social aspects of pain. Patients use the device at home, completing daily VR sessions. RelieVRx has a user-friendly interface and has received high usability ratings in clinical testing.

Expanding Access to RelieVRx

Highmark’s decision to cover RelieVRx is a major step forward in making this innovative therapy accessible to more patients. Eligible commercial members aged 18 and older diagnosed with moderate to severe CLBP can now obtain a prescription for RelieVRx from their healthcare provider without prior authorization.

“Every individual battling CLBP deserves access to noninvasive, drug-free options that empower them to self-manage their pain. Highmark’s forward-thinking approach recognizes the promise of immersive therapeutics, and we are grateful for their collaboration,” said Matthew Stoudt, Co-founder and CEO of AppliedVR. “RelieVRx is based on decades of clinical evidence demonstrating the transformative potential of immersive therapeutics to reshape the body’s response to pain, and we are committed to building an even greater body of evidence that continues to set the industry standard.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Augmented Reality, Therapeutic Virtual Reality, Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |